+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 483 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 371 Pages
  • Global
From
Antibody Fragments - Global Strategic Business Report - Product Thumbnail Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • August 2025
  • 176 Pages
  • Global
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 279 Pages
  • Global
From
Celiac Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Celiac Disease Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 371 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 380 Pages
  • Global
From
Cancer Treatment Facilities - Global Strategic Business Report - Product Thumbnail Image

Cancer Treatment Facilities - Global Strategic Business Report

  • Report
  • August 2025
  • 382 Pages
  • Global
From
From
Carcinoembryonic Antigen - Global Strategic Business Report - Product Thumbnail Image

Carcinoembryonic Antigen - Global Strategic Business Report

  • Report
  • August 2025
  • 485 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 211 Pages
  • Global
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 462 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Injectable Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 380 Pages
  • Global
From
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • August 2025
  • 386 Pages
  • Global
From
Allergic Rhinitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Allergic Rhinitis Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 563 Pages
  • Global
From
From
Polyclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • August 2025
  • 462 Pages
  • Global
From
Bispecific Antibodies - Global Strategic Business Report - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report

  • Report
  • August 2025
  • 104 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more